| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 287.500.920 $ | +73.049.237 $ | +41,2 % | 10 | 205.772.130 $ | +87.805.459 $ | +61,9 % | 8 | 148.464.960 $ | +23.080.270 $ | +63,0 % | 7 | ||||
| Erasca, Inc. | ERAS | → 0 | Neutral | 56.403.011 $ | +36.294.908 $ | +180,5 % | 1 | 20.108.103 $ | +8.324.322 $ | +70,6 % | 1 | ||||
| Entrada Therapeutics, Inc. | TRDA | → 0 | Neutral | 51.191.503 $ | +9.491.927 $ | +22,8 % | 1 | 41.699.576 $ | +17.012.578 $ | +68,9 % | 1 | 24.686.998 $ | -4.265.309 $ | -14,7 % | 1 |
| Tyra Biosciences, Inc. | TYRA | → 0 | Schwach | 39.422.113 $ | +12.361.869 $ | +45,7 % | 1 | 27.060.244 $ | +13.919.465 $ | +105,9 % | 1 | ||||
| Skye Bioscience, Inc. | SKYE | → 0 | 38.049.329 $ | -3.387.713 $ | -8,2 % | 1 | |||||||||
| Camp4 Therapeutics Corp | CAMP | → 0 | Neutral | 25.882.691 $ | -10.094.837 $ | -28,1 % | 1 | 35.977.528 $ | +18.370.255 $ | +104,3 % | 1 | 17.607.273 $ | +13.361.796 $ | +314,7 % | 1 |
| Centessa Pharmaceuticals plc | CNTA | → 0 | 23.075.135 $ | +8.545.701 $ | +58,8 % | 1 | 16.512.916 $ | +5.594.299 $ | +51,2 % | 1 | |||||
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Schwach | 22.922.836 $ | +7.027.116 $ | +44,2 % | 1 | 15.895.720 $ | +5.598.122 $ | +54,4 % | 1 | ||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 22.532.200 $ | +398.800 $ | +1,8 % | 1 | 22.133.400 $ | +2.233.280 $ | +11,2 % | 1 | 19.900.120 $ | +5.862.360 $ | +41,8 % | 1 |
| MapLight Therapeutics, Inc. | MPLT | → 0 | Schwach | 19.313.724 $ | +2.626.781 $ | +15,7 % | 1 | 16.686.943 $ | +16.686.943 $ | 1 | |||||
| EyePoint, Inc. | EYPT | → 0 | Sehr schwach | 19.183.500 $ | +4.231.500 $ | +28,3 % | 1 | ||||||||
| Tectonic Therapeutic, Inc. | TECX | → 0 | Neutral | 18.751.861 $ | +6.096.933 $ | +48,2 % | 1 | ||||||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 15.812.604 $ | +316.715 $ | +2,0 % | 1 | ||||||||
| Celldex Therapeutics, Inc. | CLDX | → 0 | Schwach | 15.773.404 $ | +2.267.551 $ | +16,8 % | 1 | ||||||||
| Artiva Biotherapeutics, Inc. | ARTV | → 0 | Schwach | 15.155.278 $ | +5.059.604 $ | +50,1 % | 1 | ||||||||
| 287.500.920 $ | +73.049.237 $ | +41,2 % | 10 | 205.772.130 $ | +87.805.459 $ | +61,9 % | 8 | 148.464.960 $ | +23.080.270 $ | +63,0 % | 7 | ||||